Inactive Instrument

All News Harpoon Therapeutics, Inc.

Equities

HARP

US41358P2056

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Harpoon Therapeutics : April 3, 2024	Apr. 03	PU
Global markets live: Domino's Pizza, Generali, Oracle, Intel, Boeing...	Mar. 12
Wall Street: start of the week down before CPI	Mar. 11	CF
Merck Completes Acquisition of Harpoon Therapeutics	Mar. 11	MT
Merck: acquisition of Harpoon Therapeutics finalized	Mar. 11	CF
Harpoon Therapeutics, Inc.(NasdaqCM:HARP) dropped from NASDAQ Composite Index	Mar. 10	CI
Merck Sharp & Dohme LLC completed the acquisition of Harpoon Therapeutics, Inc..	Mar. 10	CI
Harpoon Therapeutics, Inc.(NasdaqCM:HARP) dropped from S&P TMI Index	Mar. 10	CI
Harpoon Therapeutics : March 6, 2024	Mar. 05	PU
North American Morning Briefing : Stock Futures -2-	Feb. 27	DJ
Citigroup Downgrades Harpoon Therapeutics to Neutral From Buy, Adjusts Price Target to $23 From $13	Feb. 26	MT
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update	Jan. 23	DJ
Arix Bioscience eyes USD19 million return from Harpoon sale	Jan. 19	AN
Arix Bioscience Flags Proceeds from Merck's Purchase of Harpoon Therapeutics	Jan. 19	MT
North American Morning Briefing : Central Bankers -2-	Jan. 17	DJ
Merck To Buy Harpoon Therapeutics For $680 Million	Jan. 17	AQ
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL	Jan. 16	PR
HARPOON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Harpoon Therapeutics, Inc. - HARP	Jan. 10	BU
North American Morning Briefing : Samsung Warning -2-	Jan. 09	DJ
Arix Bioscience's Portfolio Company Signs $680 Million Takeover Deal with Merck & Co.	Jan. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Harpoon Therapeutics, Inc.

Equities

HARP

US41358P2056

All News

Filters